The aforementioned results demonstrate the potential of ARPC2 as a prospective pan-cancer prognostic biomarker, especially for ACC, HNSC, KIRC, KIRP, LGG, LIHC, MESO, PAAD, UCEC, and UVM. Here, ARPC2 is linked to adrenal cortex carcinoma.